Borlek Investments Pty Ltd

Status: Registered
Current name since: 1987-06-16
Name in the ASICs register: Borlek Investments Pty Ltd
Australian Company Number: 003233181
Australian Business Number: 85003233181
Registration date: 1987-02-02
Type: Australian proprietary company
Class: Limited by Shares
Subclass: Proprietary other
last updated

Description

Borlek Investments Pty Ltd is a limited by shares Australian proprietary company. Located at NSW 2026 since 2000-01-11 the company is, as the updated on 2000-01-11 ABN database shows, registered. Known company numbers for Borlek Investments Pty Ltd are as follows: ACN - 003233181, Australian Business Number - 85003233181. Borlek Investments Pty Ltd has been the company name since 1987-06-16. Borlek Investments Pty Ltd is one of the trading names this company has used, to be specific, the trading names list includes 1 position that is Borlek Investments Pty Ltd since 2000-01-11.

Details for ABN 85003233181

Type: Australian Private Company

ABN Status

Status From To
Active 2000-01-11 current

Main Name

Name From To
Borlek Investments Pty Ltd 2000-01-11 current

Trading Names

Name From To
Borlek Investments Pty Ltd 2000-01-11 current

Main Location

Location From To
NSW 2026 2000-01-11 current

Advertisements

Find company

NSW 2026 Location

2024 © aubiz.net - ABN Lookup, ACN, ABR, ABN Search. All rights reserved.
Contact us: info@aubiz.net
Terms of Use and Privacy Policy

Contains public sector information licensed under the Creative Commons Attribution 3.0 Australia licence. Material on this website was obtained from publicly-accessible databases and is attributed to ©Commonwealth of Australia 2024 (http://data.gov.au, http://acnc.gov.au/ and http://abr.business.gov.au/), ©Intellectual Property Government Open Data 2024, ©ASIC - Company Register. While we try to make the information as precise and up-to-date as possible, we are aware the datasets are not always error-free. Aubiz.net will not take responsibility for any errors in the databases. The material provided should be treated as a starting point of more in-depth research, not as fact.